Westpac Banking Corp acquired a new position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 32,963 shares of the healthcare conglomerate's stock, valued at approximately $13,700,000. UnitedHealth Group accounts for approximately 0.8% of Westpac Banking Corp's portfolio, making the stock its 20th largest holding.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in UNH. LFG Wealth Partners LLC raised its position in shares of UnitedHealth Group by 3.3% during the second quarter. LFG Wealth Partners LLC now owns 853 shares of the healthcare conglomerate's stock valued at $355,000 after buying an additional 27 shares during the last quarter. Synergy Financial Group LTD grew its stake in UnitedHealth Group by 3.1% during the second quarter. Synergy Financial Group LTD now owns 887 shares of the healthcare conglomerate's stock valued at $369,000 after acquiring an additional 27 shares in the last quarter. Ares Financial Consulting LLC lifted its stake in UnitedHealth Group by 7.2% in the 2nd quarter. Ares Financial Consulting LLC now owns 419 shares of the healthcare conglomerate's stock worth $174,000 after purchasing an additional 28 shares in the last quarter. Rockland Trust Co. boosted its holdings in shares of UnitedHealth Group by 1.1% during the 2nd quarter. Rockland Trust Co. now owns 2,589 shares of the healthcare conglomerate's stock valued at $1,076,000 after purchasing an additional 29 shares during the last quarter. Finally, Matrix Trust Co increased its holdings in shares of UnitedHealth Group by 24.8% in the second quarter. Matrix Trust Co now owns 146 shares of the healthcare conglomerate's stock worth $61,000 after purchasing an additional 29 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.
UnitedHealth Group Stock Up 2.3%
NYSE UNH opened at $398.89 on Tuesday. UnitedHealth Group Incorporated has a 52 week low of $255.96 and a 52 week high of $461.62. The firm has a market capitalization of $358.04 billion, a price-to-earnings ratio of 25.67, a PEG ratio of 1.35 and a beta of 0.62. The company has a quick ratio of 0.78, a current ratio of 0.78 and a debt-to-equity ratio of 0.66. The company has a fifty day moving average of $413.74 and a two-hundred day moving average of $357.26.
UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.94 by $1.44. The firm had revenue of $112.03 billion during the quarter, compared to analyst estimates of $110.81 billion. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. The business's revenue was up .4% on a year-over-year basis. During the same quarter last year, the business earned $4.08 EPS. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. On average, analysts predict that UnitedHealth Group Incorporated will post 19.81 earnings per share for the current year.
UnitedHealth Group Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 22nd. Stockholders of record on Monday, September 14th will be paid a dividend of $2.32 per share. The ex-dividend date of this dividend is Monday, September 14th. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.3%. UnitedHealth Group's dividend payout ratio is currently 59.72%.
Analysts Set New Price Targets
Several equities analysts have weighed in on the company. Wall Street Zen upgraded UnitedHealth Group from a "hold" rating to a "buy" rating in a report on Saturday, August 8th. Zacks Research raised shares of UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a research note on Monday, July 13th. Erste Group Bank raised shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a research note on Monday, April 27th. Sanford C. Bernstein restated an "outperform" rating on shares of UnitedHealth Group in a research report on Tuesday, July 21st. Finally, Wells Fargo & Company lifted their price target on UnitedHealth Group from $397.00 to $485.00 and gave the stock an "overweight" rating in a research report on Monday, July 13th. Two research analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat.com, UnitedHealth Group presently has a consensus rating of "Moderate Buy" and an average target price of $455.92.
Get Our Latest Report on UnitedHealth Group
Insider Activity
In related news, CEO Patrick Hugh Conway sold 500 shares of the firm's stock in a transaction that occurred on Wednesday, August 5th. The stock was sold at an average price of $410.00, for a total transaction of $205,000.00. Following the completion of the sale, the chief executive officer directly owned 16,497 shares of the company's stock, valued at approximately $6,763,770. This trade represents a 2.94% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 0.19% of the company's stock.
About UnitedHealth Group
(
Free Report)
UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.
UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.
Recommended Stories
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.